16-10916787-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000246.4(CIITA):​c.3062+328C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.136 in 430,092 control chromosomes in the GnomAD database, including 4,877 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 1862 hom., cov: 33)
Exomes 𝑓: 0.13 ( 3015 hom. )

Consequence

CIITA
NM_000246.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.307

Publications

3 publications found
Variant links:
Genes affected
CIITA (HGNC:7067): (class II major histocompatibility complex transactivator) This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
CIITA Gene-Disease associations (from GenCC):
  • MHC class II deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CIITANM_000246.4 linkc.3062+328C>T intron_variant Intron 15 of 19 ENST00000324288.14 NP_000237.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CIITAENST00000324288.14 linkc.3062+328C>T intron_variant Intron 15 of 19 1 NM_000246.4 ENSP00000316328.8

Frequencies

GnomAD3 genomes
AF:
0.142
AC:
21613
AN:
152130
Hom.:
1850
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.152
Gnomad AMI
AF:
0.0890
Gnomad AMR
AF:
0.271
Gnomad ASJ
AF:
0.0781
Gnomad EAS
AF:
0.146
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.117
Gnomad OTH
AF:
0.139
GnomAD4 exome
AF:
0.133
AC:
36893
AN:
277844
Hom.:
3015
Cov.:
0
AF XY:
0.129
AC XY:
18561
AN XY:
143894
show subpopulations
African (AFR)
AF:
0.155
AC:
1450
AN:
9360
American (AMR)
AF:
0.335
AC:
3823
AN:
11420
Ashkenazi Jewish (ASJ)
AF:
0.0780
AC:
768
AN:
9848
East Asian (EAS)
AF:
0.196
AC:
3840
AN:
19558
South Asian (SAS)
AF:
0.122
AC:
4556
AN:
37250
European-Finnish (FIN)
AF:
0.110
AC:
1072
AN:
9772
Middle Eastern (MID)
AF:
0.137
AC:
167
AN:
1216
European-Non Finnish (NFE)
AF:
0.116
AC:
18954
AN:
162868
Other (OTH)
AF:
0.137
AC:
2263
AN:
16552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1498
2997
4495
5994
7492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.142
AC:
21653
AN:
152248
Hom.:
1862
Cov.:
33
AF XY:
0.145
AC XY:
10815
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.152
AC:
6317
AN:
41530
American (AMR)
AF:
0.271
AC:
4147
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0781
AC:
271
AN:
3470
East Asian (EAS)
AF:
0.146
AC:
757
AN:
5182
South Asian (SAS)
AF:
0.131
AC:
631
AN:
4826
European-Finnish (FIN)
AF:
0.107
AC:
1133
AN:
10614
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.117
AC:
7976
AN:
68024
Other (OTH)
AF:
0.142
AC:
301
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
923
1846
2769
3692
4615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.158
Hom.:
473
Bravo
AF:
0.158
Asia WGS
AF:
0.205
AC:
714
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.12
DANN
Benign
0.68
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6498132; hg19: chr16-11010644; API